Eintrag weiter verarbeiten
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
Gespeichert in:
Zeitschriftentitel: | ACS Medicinal Chemistry Letters |
---|---|
Personen und Körperschaften: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
In: | ACS Medicinal Chemistry Letters, 2, 2011, 6, S. 450-454 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
American Chemical Society (ACS)
|
Schlagwörter: |
author_facet |
Xue, Chu-Biao Feng, Hao Cao, Ganfeng Huang, Taisheng Glenn, Joseph Anand, Rajan Meloni, David Zhang, Ke Kong, Lingquan Wang, Anlai Zhang, Yingxin Zheng, Changsheng Xia, Michael Chen, Lihua Tanaka, Hiroyuki Han, Qi Robinson, D. J. Modi, Dilip Storace, Lou Shao, Lixin Sharief, Vaqar Li, Mei Galya, Laurine G. Covington, Maryanne Scherle, Peggy Diamond, Sharon Emm, Tom Yeleswaram, Swamy Contel, Nancy Vaddi, Kris Newton, Robert Hollis, Greg Friedman, Steven Metcalf, Brian Xue, Chu-Biao Feng, Hao Cao, Ganfeng Huang, Taisheng Glenn, Joseph Anand, Rajan Meloni, David Zhang, Ke Kong, Lingquan Wang, Anlai Zhang, Yingxin Zheng, Changsheng Xia, Michael Chen, Lihua Tanaka, Hiroyuki Han, Qi Robinson, D. J. Modi, Dilip Storace, Lou Shao, Lixin Sharief, Vaqar Li, Mei Galya, Laurine G. Covington, Maryanne Scherle, Peggy Diamond, Sharon Emm, Tom Yeleswaram, Swamy Contel, Nancy Vaddi, Kris Newton, Robert Hollis, Greg Friedman, Steven Metcalf, Brian |
---|---|
author |
Xue, Chu-Biao Feng, Hao Cao, Ganfeng Huang, Taisheng Glenn, Joseph Anand, Rajan Meloni, David Zhang, Ke Kong, Lingquan Wang, Anlai Zhang, Yingxin Zheng, Changsheng Xia, Michael Chen, Lihua Tanaka, Hiroyuki Han, Qi Robinson, D. J. Modi, Dilip Storace, Lou Shao, Lixin Sharief, Vaqar Li, Mei Galya, Laurine G. Covington, Maryanne Scherle, Peggy Diamond, Sharon Emm, Tom Yeleswaram, Swamy Contel, Nancy Vaddi, Kris Newton, Robert Hollis, Greg Friedman, Steven Metcalf, Brian |
spellingShingle |
Xue, Chu-Biao Feng, Hao Cao, Ganfeng Huang, Taisheng Glenn, Joseph Anand, Rajan Meloni, David Zhang, Ke Kong, Lingquan Wang, Anlai Zhang, Yingxin Zheng, Changsheng Xia, Michael Chen, Lihua Tanaka, Hiroyuki Han, Qi Robinson, D. J. Modi, Dilip Storace, Lou Shao, Lixin Sharief, Vaqar Li, Mei Galya, Laurine G. Covington, Maryanne Scherle, Peggy Diamond, Sharon Emm, Tom Yeleswaram, Swamy Contel, Nancy Vaddi, Kris Newton, Robert Hollis, Greg Friedman, Steven Metcalf, Brian ACS Medicinal Chemistry Letters Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist Organic Chemistry Drug Discovery Biochemistry |
author_sort |
xue, chu-biao |
spelling |
Xue, Chu-Biao Feng, Hao Cao, Ganfeng Huang, Taisheng Glenn, Joseph Anand, Rajan Meloni, David Zhang, Ke Kong, Lingquan Wang, Anlai Zhang, Yingxin Zheng, Changsheng Xia, Michael Chen, Lihua Tanaka, Hiroyuki Han, Qi Robinson, D. J. Modi, Dilip Storace, Lou Shao, Lixin Sharief, Vaqar Li, Mei Galya, Laurine G. Covington, Maryanne Scherle, Peggy Diamond, Sharon Emm, Tom Yeleswaram, Swamy Contel, Nancy Vaddi, Kris Newton, Robert Hollis, Greg Friedman, Steven Metcalf, Brian 1948-5875 1948-5875 American Chemical Society (ACS) Organic Chemistry Drug Discovery Biochemistry http://dx.doi.org/10.1021/ml200030q Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist ACS Medicinal Chemistry Letters |
doi_str_mv |
10.1021/ml200030q |
facet_avail |
Online Free |
finc_class_facet |
Chemie und Pharmazie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAyMS9tbDIwMDAzMHE |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAyMS9tbDIwMDAzMHE |
institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-105 DE-Ch1 DE-L229 |
imprint |
American Chemical Society (ACS), 2011 |
imprint_str_mv |
American Chemical Society (ACS), 2011 |
issn |
1948-5875 |
issn_str_mv |
1948-5875 |
language |
English |
mega_collection |
American Chemical Society (ACS) (CrossRef) |
match_str |
xue2011discoveryofincb3284apotentselectiveandorallybioavailablehccr2antagonist |
publishDateSort |
2011 |
publisher |
American Chemical Society (ACS) |
recordtype |
ai |
record_format |
ai |
series |
ACS Medicinal Chemistry Letters |
source_id |
49 |
title |
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_unstemmed |
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_full |
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_fullStr |
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_full_unstemmed |
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_short |
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_sort |
discovery of incb3284, a potent, selective, and orally bioavailable hccr2 antagonist |
topic |
Organic Chemistry Drug Discovery Biochemistry |
url |
http://dx.doi.org/10.1021/ml200030q |
publishDate |
2011 |
physical |
450-454 |
description |
|
container_issue |
6 |
container_start_page |
450 |
container_title |
ACS Medicinal Chemistry Letters |
container_volume |
2 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792343106900721677 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T16:46:24.671Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Discovery+of+INCB3284%2C+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+hCCR2+Antagonist&rft.date=2011-06-09&genre=article&issn=1948-5875&volume=2&issue=6&spage=450&epage=454&pages=450-454&jtitle=ACS+Medicinal+Chemistry+Letters&atitle=Discovery+of+INCB3284%2C+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+hCCR2+Antagonist&aulast=Metcalf&aufirst=Brian&rft_id=info%3Adoi%2F10.1021%2Fml200030q&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792343106900721677 |
author | Xue, Chu-Biao, Feng, Hao, Cao, Ganfeng, Huang, Taisheng, Glenn, Joseph, Anand, Rajan, Meloni, David, Zhang, Ke, Kong, Lingquan, Wang, Anlai, Zhang, Yingxin, Zheng, Changsheng, Xia, Michael, Chen, Lihua, Tanaka, Hiroyuki, Han, Qi, Robinson, D. J., Modi, Dilip, Storace, Lou, Shao, Lixin, Sharief, Vaqar, Li, Mei, Galya, Laurine G., Covington, Maryanne, Scherle, Peggy, Diamond, Sharon, Emm, Tom, Yeleswaram, Swamy, Contel, Nancy, Vaddi, Kris, Newton, Robert, Hollis, Greg, Friedman, Steven, Metcalf, Brian |
author_facet | Xue, Chu-Biao, Feng, Hao, Cao, Ganfeng, Huang, Taisheng, Glenn, Joseph, Anand, Rajan, Meloni, David, Zhang, Ke, Kong, Lingquan, Wang, Anlai, Zhang, Yingxin, Zheng, Changsheng, Xia, Michael, Chen, Lihua, Tanaka, Hiroyuki, Han, Qi, Robinson, D. J., Modi, Dilip, Storace, Lou, Shao, Lixin, Sharief, Vaqar, Li, Mei, Galya, Laurine G., Covington, Maryanne, Scherle, Peggy, Diamond, Sharon, Emm, Tom, Yeleswaram, Swamy, Contel, Nancy, Vaddi, Kris, Newton, Robert, Hollis, Greg, Friedman, Steven, Metcalf, Brian, Xue, Chu-Biao, Feng, Hao, Cao, Ganfeng, Huang, Taisheng, Glenn, Joseph, Anand, Rajan, Meloni, David, Zhang, Ke, Kong, Lingquan, Wang, Anlai, Zhang, Yingxin, Zheng, Changsheng, Xia, Michael, Chen, Lihua, Tanaka, Hiroyuki, Han, Qi, Robinson, D. J., Modi, Dilip, Storace, Lou, Shao, Lixin, Sharief, Vaqar, Li, Mei, Galya, Laurine G., Covington, Maryanne, Scherle, Peggy, Diamond, Sharon, Emm, Tom, Yeleswaram, Swamy, Contel, Nancy, Vaddi, Kris, Newton, Robert, Hollis, Greg, Friedman, Steven, Metcalf, Brian |
author_sort | xue, chu-biao |
container_issue | 6 |
container_start_page | 450 |
container_title | ACS Medicinal Chemistry Letters |
container_volume | 2 |
description | |
doi_str_mv | 10.1021/ml200030q |
facet_avail | Online, Free |
finc_class_facet | Chemie und Pharmazie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAyMS9tbDIwMDAzMHE |
imprint | American Chemical Society (ACS), 2011 |
imprint_str_mv | American Chemical Society (ACS), 2011 |
institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229 |
issn | 1948-5875 |
issn_str_mv | 1948-5875 |
language | English |
last_indexed | 2024-03-01T16:46:24.671Z |
match_str | xue2011discoveryofincb3284apotentselectiveandorallybioavailablehccr2antagonist |
mega_collection | American Chemical Society (ACS) (CrossRef) |
physical | 450-454 |
publishDate | 2011 |
publishDateSort | 2011 |
publisher | American Chemical Society (ACS) |
record_format | ai |
recordtype | ai |
series | ACS Medicinal Chemistry Letters |
source_id | 49 |
spelling | Xue, Chu-Biao Feng, Hao Cao, Ganfeng Huang, Taisheng Glenn, Joseph Anand, Rajan Meloni, David Zhang, Ke Kong, Lingquan Wang, Anlai Zhang, Yingxin Zheng, Changsheng Xia, Michael Chen, Lihua Tanaka, Hiroyuki Han, Qi Robinson, D. J. Modi, Dilip Storace, Lou Shao, Lixin Sharief, Vaqar Li, Mei Galya, Laurine G. Covington, Maryanne Scherle, Peggy Diamond, Sharon Emm, Tom Yeleswaram, Swamy Contel, Nancy Vaddi, Kris Newton, Robert Hollis, Greg Friedman, Steven Metcalf, Brian 1948-5875 1948-5875 American Chemical Society (ACS) Organic Chemistry Drug Discovery Biochemistry http://dx.doi.org/10.1021/ml200030q Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist ACS Medicinal Chemistry Letters |
spellingShingle | Xue, Chu-Biao, Feng, Hao, Cao, Ganfeng, Huang, Taisheng, Glenn, Joseph, Anand, Rajan, Meloni, David, Zhang, Ke, Kong, Lingquan, Wang, Anlai, Zhang, Yingxin, Zheng, Changsheng, Xia, Michael, Chen, Lihua, Tanaka, Hiroyuki, Han, Qi, Robinson, D. J., Modi, Dilip, Storace, Lou, Shao, Lixin, Sharief, Vaqar, Li, Mei, Galya, Laurine G., Covington, Maryanne, Scherle, Peggy, Diamond, Sharon, Emm, Tom, Yeleswaram, Swamy, Contel, Nancy, Vaddi, Kris, Newton, Robert, Hollis, Greg, Friedman, Steven, Metcalf, Brian, ACS Medicinal Chemistry Letters, Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist, Organic Chemistry, Drug Discovery, Biochemistry |
title | Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_full | Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_fullStr | Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_full_unstemmed | Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_short | Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
title_sort | discovery of incb3284, a potent, selective, and orally bioavailable hccr2 antagonist |
title_unstemmed | Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist |
topic | Organic Chemistry, Drug Discovery, Biochemistry |
url | http://dx.doi.org/10.1021/ml200030q |